Female Viagra Disapproved by FDA

In a setback for horny women everywhere, the FDA recently wagged a finger at the drug flibanserin, which was designed to boost a lacking libido in women. Even though the drug was proven to give a woman more “sexually satisfying events,” the regulators said it did not treat a problem that can be diagnosed. While these satisfying events increased, the women’s actual sexual desire did not, so the feds saw this as not treating female sexual desire disorder, an identifiable health problem.

Where is the fun in that interpretation? The FDA dropped the ball on this and blocked a perfectly good sex pill. At the end of the day, it would be a case of ladies still having to get themselves in the mood, but the experience would be much better once it happened.

As for side effects, what was seen in the trials was dizziness, fatigue, and nausea. Sounds like what happens after a few glasses of wines, so not much risk there. It is not close to the four hour boners, heart attacks, and blindness you hear as side effects on Viagra commercials.

This ruling leaves women everywhere at risk of having fewer “sexually satisfying events.” Now it is back to the drawing board on how to increase female libido. What we currently have to work with are testosterone drugs in patch or gel form, which are nice but have not proven to be clear winners. One sure thing is that when the big breakthrough does come about, it should be a celebration to remember.

Tags: , , , , , , , , , , , , , , , , , , ,

No comments yet.

Leave a Reply